blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2547324

EP2547324 - PROCESS OF MANUFACTURING A LYOPHILIZED FAST DISSOLVING, MUTLI-PHASIC DOSAGE FORM [Right-click to bookmark this link]
Former [2013/04]PROCESS OF MANUFACTURING A LYOPHILIZED FAST DISSOLVING, MUTI-PHASIC DOSAGE FORM
[2018/35]
StatusNo opposition filed within time limit
Status updated on  03.07.2020
Database last updated on 14.09.2024
FormerThe patent has been granted
Status updated on  21.06.2019
FormerGrant of patent is intended
Status updated on  30.07.2018
FormerExamination is in progress
Status updated on  27.12.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Catalent U.K. Swindon Zydis Limited
Capella Building (Tenth Floor)
60 York Street
Glasgow G2 8JX / GB
[2019/29]
Former [2013/20]For all designated states
R.P. Scherer Technologies, LLC
CSC Services of Nevada, Inc.
502 East John Street
Carson City, NV 89706 / US
Former [2013/04]For all designated states
Catalent Pharma Solutions, LLC
14 Schoolhouse Road
Somerset, NJ 07083 / US
For all designated states
Tian, Wei
6 Sawyers Close
Minety, Wiltshire SN16 9QS / GB
Inventor(s)01 / TIAN, Wei
The Paddock
4 Brownrigg Farm
Cleghorn
Lanark ML11 8NX Scotland / GB
 [2017/32]
Former [2013/04]01 / TIAN, Wei
6 Sawyers Close
Minety
Wiltshire SN16 9QS / GB
Representative(s)De Vries & Metman
Overschiestraat 180
1062 XK Amsterdam / NL
[2019/30]
Former [2013/37]Dunleavy, Kevin James, et al
Mendelsohn, Drucker and Dunleavy, P.C.
p/o De Vries & Metman
Overschiestraat 180
1062 XK Amsterdam / NL
Former [2013/04]Dunleavy, Kevin James, et al
Mendelsohn, Drucker & Associates, P.C.
p/o De Vries & Metman
Overschiestraat 180
1062 XK Amsterdam / NL
Application number, filing date11712090.715.03.2011
[2019/30]
WO2011US28483
Priority number, dateUS2010072460116.03.2010         Original published format: US 724601
[2013/04]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011115969
Date:22.09.2011
Language:EN
[2011/38]
Type: A2 Application without search report 
No.:EP2547324
Date:23.01.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 22.09.2011 takes the place of the publication of the European patent application.
[2013/04]
Type: B1 Patent specification 
No.:EP2547324
Date:24.07.2019
Language:EN
[2019/30]
Search report(s)International search report - published on:EP26.04.2012
ClassificationIPC:A61K9/19, A61K9/20, A61K9/00, A61K9/24
[2018/32]
CPC:
A61K9/0056 (EP,US); A61K9/209 (EP,KR,US); A61K47/30 (KR);
A61K9/19 (EP,US); A61K9/20 (KR); A61K9/2018 (EP,US);
A61K9/2059 (EP,US); A61K9/2063 (EP,US); A61K9/28 (KR);
A61P1/04 (EP); A61P25/24 (EP); A61P29/00 (EP);
A61P3/10 (EP); A61P31/12 (EP); A61P35/00 (EP);
A61P37/06 (EP); A61P7/02 (EP) (-)
Former IPC [2013/04]A61K9/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/04]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG EINER LYOPHILISIERTEN SCHNELL LÖSLICHEN MEHRPHASIGEN DARREICHUNGSFORM[2013/04]
English:PROCESS OF MANUFACTURING A LYOPHILIZED FAST DISSOLVING, MUTLI-PHASIC DOSAGE FORM[2018/35]
French:PROCÉDÉ DE FABRICATION D'UNE FORME POSOLOGIQUE MULTIPHASIQUE À DISSOLUTION RAPIDE, LYOPHILISÉE[2013/04]
Former [2013/04]PROCESS OF MANUFACTURING A LYOPHILIZED FAST DISSOLVING, MUTI-PHASIC DOSAGE FORM
Entry into regional phase22.09.2012National basic fee paid 
22.09.2012Designation fee(s) paid 
22.09.2012Examination fee paid 
Examination procedure22.09.2012Examination requested  [2013/04]
22.05.2013Amendment by applicant (claims and/or description)
02.08.2013Despatch of a communication from the examining division (Time limit: M04)
12.12.2013Reply to a communication from the examining division
04.12.2015Despatch of a communication from the examining division (Time limit: M04)
14.04.2016Reply to a communication from the examining division
16.12.2016Despatch of a communication from the examining division (Time limit: M06)
25.06.2017Reply to a communication from the examining division
01.12.2017Despatch of a communication from the examining division (Time limit: M04)
09.03.2018Reply to a communication from the examining division
31.07.2018Communication of intention to grant the patent
27.11.2018Fee for grant paid
27.11.2018Fee for publishing/printing paid
27.11.2018Receipt of the translation of the claim(s)
Divisional application(s)EP19187851.1   Application deemed to be withdrawn  : 24.01.2020
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.08.2013
Opposition(s)03.06.2020No opposition filed within time limit [2020/32]
Fees paidRenewal fee
11.03.2013Renewal fee patent year 03
12.03.2014Renewal fee patent year 04
10.03.2015Renewal fee patent year 05
10.03.2016Renewal fee patent year 06
10.03.2017Renewal fee patent year 07
13.03.2018Renewal fee patent year 08
13.03.2019Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.03.2011
AL24.07.2019
AT24.07.2019
CY24.07.2019
CZ24.07.2019
EE24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
MK24.07.2019
MT24.07.2019
NL24.07.2019
PL24.07.2019
RO24.07.2019
RS24.07.2019
SE24.07.2019
SI24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
IE15.03.2020
LU15.03.2020
BE31.03.2020
[2022/32]
Former [2022/27]HU15.03.2011
AL24.07.2019
AT24.07.2019
CY24.07.2019
CZ24.07.2019
EE24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
MT24.07.2019
NL24.07.2019
PL24.07.2019
RO24.07.2019
RS24.07.2019
SE24.07.2019
SI24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
IE15.03.2020
LU15.03.2020
BE31.03.2020
Former [2021/12]AL24.07.2019
AT24.07.2019
CZ24.07.2019
EE24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
NL24.07.2019
PL24.07.2019
RO24.07.2019
RS24.07.2019
SE24.07.2019
SI24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
IE15.03.2020
LU15.03.2020
BE31.03.2020
Former [2021/08]AL24.07.2019
AT24.07.2019
CZ24.07.2019
EE24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
NL24.07.2019
PL24.07.2019
RO24.07.2019
RS24.07.2019
SE24.07.2019
SI24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
IE15.03.2020
LU15.03.2020
Former [2021/04]AL24.07.2019
AT24.07.2019
CZ24.07.2019
EE24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
NL24.07.2019
PL24.07.2019
RO24.07.2019
RS24.07.2019
SE24.07.2019
SI24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
LU15.03.2020
Former [2020/49]AL24.07.2019
AT24.07.2019
CZ24.07.2019
EE24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
NL24.07.2019
PL24.07.2019
RO24.07.2019
RS24.07.2019
SE24.07.2019
SI24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/37]AL24.07.2019
AT24.07.2019
CZ24.07.2019
EE24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
NL24.07.2019
PL24.07.2019
RO24.07.2019
RS24.07.2019
SE24.07.2019
SI24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/36]AL24.07.2019
AT24.07.2019
CZ24.07.2019
EE24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
NL24.07.2019
PL24.07.2019
RO24.07.2019
RS24.07.2019
SE24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/27]AL24.07.2019
AT24.07.2019
CZ24.07.2019
EE24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
NL24.07.2019
PL24.07.2019
RO24.07.2019
RS24.07.2019
SE24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
PT25.11.2019
IS24.02.2020
Former [2020/25]AL24.07.2019
AT24.07.2019
CZ24.07.2019
EE24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
NL24.07.2019
PL24.07.2019
RO24.07.2019
RS24.07.2019
SE24.07.2019
SK24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
PT25.11.2019
IS24.02.2020
Former [2020/24]AL24.07.2019
AT24.07.2019
EE24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
NL24.07.2019
PL24.07.2019
RO24.07.2019
RS24.07.2019
SE24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
PT25.11.2019
IS24.02.2020
Former [2020/23]AL24.07.2019
AT24.07.2019
EE24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
NL24.07.2019
PL24.07.2019
RO24.07.2019
RS24.07.2019
SE24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/22]AL24.07.2019
AT24.07.2019
EE24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
NL24.07.2019
RS24.07.2019
SE24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/17]AL24.07.2019
AT24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
NL24.07.2019
RS24.07.2019
SE24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/15]AL24.07.2019
AT24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
NL24.07.2019
RS24.07.2019
SE24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/12]AT24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
NL24.07.2019
RS24.07.2019
SE24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/11]AT24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
NL24.07.2019
RS24.07.2019
SE24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
PT25.11.2019
Former [2020/10]AT24.07.2019
FI24.07.2019
LT24.07.2019
NL24.07.2019
SE24.07.2019
BG24.10.2019
NO24.10.2019
PT25.11.2019
Former [2020/09]FI24.07.2019
LT24.07.2019
NL24.07.2019
NO24.10.2019
Former [2020/08]LT24.07.2019
NL24.07.2019
NO24.10.2019
Former [2020/07]NL24.07.2019
Cited inInternational search[X]FR1373287  (ERBA CARLO SPA) [X] 1-21 * column 1; example 1; claims 1-5 *;
 [XDI]WO0061117  (SCHERER CORP R P [US], et al) [XD] 19-21 * examples 1-4; claims 1-20 * [I] 1-18;
 [AD]WO2006063189  (NOVARTIS AG [CH], et al) [AD] 1-21* examples 1-5; claims 1-26 *;
 [X]EP1980245  (CEPHALON FRANCE [FR], et al) [X] 1-21 * paragraph [0113]; examples 6,8; claims 1-55 *
ExaminationWO2004043440
by applicantGB1548022
 US5039540
 WO0050013
 WO0061117
 US6709669
 WO2004066924
 WO2006063189
    - SEAGAR, H., "Drug-Delivery Products and Zydis Fast Dissolving Dosage Form", J. PHARM. PHARMACO, (1998), vol. 50, pages 375 - 382, XP001037891
    - "Gels and Jellies", JAMES SWARBRICK, Encyclopedia of Pharmaceutical Technology, (2007), vol. 3, page 1875
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.